Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06588101

Clinical Trial Recruitment and Retention Strategies for Family Members in the ICU

There is a need to identify strategies that improve the conduct of clinical trials involving family members of intensive care unit (ICU) patients. The purpose of the present study is to evaluate recruitment and retention strategies for clinical trials involving family members of ICU patients. 4 strategies (2 recruitment and 2 retention) will be tested. Investigators will integrate the strategies into three existing studies that involve family members of ICU patients. Participants will be randomized using a 2x2 factorial design. The co-primary outcomes are recruitment percentage (participants enrolled/participants approached) and retention percentage (participants completing follow-up/participants enrolled).

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Jewish General Hospital

Montreal, Quebec, Canada

Location status: Recruiting

Location contact

Jillian Kifell, MSc

CONTACT

[email protected]

5143408222 ext. 25806

Michael J Goldfarb, MD, MSc

PRINCIPAL_INVESTIGATOR

About this study

Family engagement in the ICU is recommended by critical care professional societies, but insufficient evidence of its benefits for patients and family members has hindered clinical uptake. Thus, high-quality evidence is needed to promote and support family engagement practices. A specific unmet need is to identify strategies to improve the recruitment and retention of families in clinical trials in the ICU setting. The objective of this study is to evaluate recruitment and retention strategies for clinical trials involving family members in the ICU setting.

Methodological Approach: Investigators will use a Study Within a Trial (SWAT) design to embed a factorial randomized trial of 160 participants enrolled across investigator group's three ongoing studies involving family members of ICU patients: FAME, VR-Family, and NGAGE. Investigators expect 160 participants to be enrolled over a 6-month period. Participants will be randomized by 2x2 factorial design to selected recruitment and/or retention strategies. The co-primary outcomes will be (1) recruitment rate and (2) retention rate.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Has family member admitted to an intensive care unit.
  • Expected hospital stay > 48 hours
  • Able to participate in English or French

Exclusion criteria

  • Has another family member participating in the trial
  • Repeat admissions within the study period

Treatment and study plan

Written informed consent with infographic

Other

Potential participants are provided a visual infographic depicting the key elements of the written consent form in addition to the standard written consent form.

Compensation

Other

Potential participants are provided an e-gift card to Amazon or Second Cup as a reward for completing the enrollment questionnaire.

Primary outcomes

  1. Recruitment percentage

    Time frame: At enrolment

    Family member participants enrolled/ family member participants approached

  2. Retention percentage

    Time frame: From enrolment until 6 month follow-up completion

    Family member participant completing follow-up/family member participants enrolled

Study contacts

Contact information is provided by the study sponsor or research team.

Jillian Kifell, MSc

CONTACT

[email protected]

5143408222 ext. 25806

Sponsors and collaborators

Lead sponsor

Lady Davis Institute

Other

Collaborators

  • Canadian Institutes of Health Research (CIHR)

Registry information

Official study title

Clinical Trial Recruitment and Retention Strategies for Family Members in the Intensive Care Unit: A Study Within A Trial Randomized Design

Acronym: SWAT

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Sep 19, 2024
Registry last updated
Jun 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.